Retrospective single-center study shows effective endovascular treatment for symptomatic dissection, suggesting favorable outcomes.
< .001). The rate of adverse events and early re-intervention was 6.5% (6/93) and 5.4% (5/93). The median follow-up time was 27 months (range 6-64), and there was 1 case of late re-intervention, 1 case of stent occlusion, and no dissection-related deaths. Endovascular treatment showed a satisfactory outcome in treating symptomatic SISMAD, with a good cumulative complete remodeling rate.
No takes yet. Share an insight, caveat, or question.
Weng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: